MS Protocols
MS TherapiesCommon ConcernsContactFrançais

COMMON CONCERNS

PML Management

Progressive Multifocal Leukoencephalopathy (PML) is an opportunistic infection whose classic histopathological triad of demyelination, bizarre astrocytes and oligodendrogial nuclear inclusion was first described in 1958. It was in 1971 that the polyoma virus, John Cunningham (JC), was discovered to be the cause of the infection. Click below to learn more.

learn more

Pregnancy

It was not that long ago that neurologists recommended to patients to avoid getting pregnant for fear of worsening the disease course. We can now confidently affirm that multiple sclerosis does not affect pregnancy or the fetus. The risk of developing MS in the offspring is proportional to the genetic loading as pregnancy affects the course of the disease.

learn more

Vaccination

Vaccination is an important preventative measure for our MS patients.There is much debate whether a given therapy is immunosuppressive or not. In the author’s view, any therapy that can lead to any or all of the following is an immunosuppressive agent such as causing sustained lymphopenia and/or neutropenia and reducing the immune system.

learn more

contact Clinique Neuro-Outaouais:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

navigation

MS TherapiesCommon ConcernsFrançais
© 2016 Arkade. All Rights Reserved.
Arkade and Clinique Neuro-Outaouais accept no
responsibility for the consequences arising from the
application of the information on this website.